What if you could take a simple test to reveal your individual risk of developing a range of cancers and hundreds of other diseases?
Articles on Ovarian cancer
Displaying 21 - 40 of 40 articles
Jolie Pitt has announced more surgery, this time to mitigate her risk of developing ovarian cancer. But this should ideally not have the same “Jolie effect” as her last operation.
Genetic testing for cancer will become more common and risk reducing surgery is one way to cut the risk.
It is well established that faults in the BRCA2 gene (and the BRCA1 gene that prompted actress Angelina Jolie to undergo a mastectomy) increase the risk of breast, ovarian, prostate and other cancers…
Ovarian cancer is the fifth highest killer in women when it comes to cancer, according to statistics from the American Cancer Society, with about 14,000 deaths in the United States alone this year. The…
Most cancers happen by chance and there is no obvious inherited reason for them. However a small proportion of cancers occur as a result of a genetic predisposition because a gene passed down through generation…
Women with the BRCA1 mutation should have their ovaries removed before the age of 35 to reduce their risk of ovarian and…
New understandings of inflammation processes in cancer patients could lead to expanded treatment options for some types of…
Researchers in the United States have developed a new model to predict women’s risk of developing breast, uterine and ovarian cancer, based on individual lifestyle factors. These three cancers make up…
Following Hollywood actress Angelina Jolie’s revelation last week that she’d undergone a double mastectomy to prevent breast cancer, it has emerged that a 53-year-old man had his prostate removed after…
Angelina Jolie’s recent announcement about her double mastectomy likely caused many women to think about their own chance of developing breast cancer. But before you rush off to have a bunch of possibly…
Actress Angelina Jolie’s op-ed in the New York Times explained that she opted to have a double mastectomy because she carries the hereditary BRCA1 gene, which she says increases her risk of breast cancer…
“The issue that arises in this case is of considerable importance. It relates to the patentability of genes, or gene sequences, and the practice of gene patenting”. So began the reasons for judgement of…
Scientists have successfully re-implanted ovarian tissue into a 43 year old woman, resulting in pregnancy. The procedure…
Women who breastfeed their babies have significantly reduced rates of ovarian cancer, according to a new study. The study…
Cancer has been a National Health Priority Area since 1996 because of the burden it places on the Australian community. Of course, cancer isn’t just a health and economic burden – it takes an enormous…
Women with a history of endometriosis are more likely to develop three different types of ovarian cancer. More than 23,000…
Researchers have identified biochemical changes that commonly occur in the DNA of women with ovarian cancer, which may help…
Women who carry genes that predispose them to getting cancer at a young age may be passing the gene onto the next generation and causing cancers to develop at ever younger ages, a new study has found…
We are bombarded with health messages on an almost daily basis. Many of these encourage us to monitor ourselves for worrying signs that might be signals of an underlying problem. Ovarian cancer is the…
Top contributors
-
Clinical Professorial Research Fellow, Australian Women and Girls' Health Research Centre, The University of Queensland
-
Medical Oncologist and Laboratory Head, WEHI (Walter and Eliza Hall Institute of Medical Research)
-
Consultant Senior Lecturer in Clinical Genetics, UCL
-
Adjunct Professsor, School of Psychology, Faculty of Health and Medical Sciences, Adelaide University
-
Professor and Cancer Theme Leader, South Australian Health & Medical Research Institute
-
Reader in Biomedical Sciences, University of Hull
-
Professor of Biochemistry, University of Aberdeen
-
PhD student in Biology, University of Rochester
-
Senior Manager, Descriptive Epidemiology, Cancer Council Queensland
-
Professor of Interdisciplinary Parasitology, University of Nottingham
-
Lab Head, Gynaecological Cancer Research Group, Lowy Cancer Rearch Centre, UNSW
-
Professor of Macromolecular Structure and Function, Imperial College London
-
Senior Lecturer and Consultant in Gynaecological Oncology, Imperial College London
-
Professor of Oncology, Head of the RMH Familial Cancer Centre and Joint Head, Breast Cancer Laboratory, WEHI (Walter and Eliza Hall Institute of Medical Research)
-
Professor of Genome Sciences, University of Washington